{"id":"NCT01926197","sponsor":"Stanford University","briefTitle":"Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer","officialTitle":"A Randomized Phase III Study Evaluating Modified FOLFIRINOX (mFFX) With or Without Stereotactic Body Radiotherapy (SBRT) in the Treatment of Locally Advanced Pancreatic Cancer: A Pancreatic Cancer Radiotherapy Study Group (PanCRS) Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08-14","primaryCompletion":"2021-09-30","completion":"2022-09-30","firstPosted":"2013-08-20","resultsPosted":"2022-10-28","lastUpdate":"2022-10-28"},"enrollment":27,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pancreatic Cancer"],"interventions":[{"type":"DRUG","name":"Oxaliplatin","otherNames":["Eloxatin"]},{"type":"DRUG","name":"Irinotecan","otherNames":["Camptosar","Camptothecin-11 (CPT-11)","Campto","Onivyde"]},{"type":"DRUG","name":"Leucovorin","otherNames":["Folinic acid","Wellcovorin","Citrovorum Factor"]},{"type":"DRUG","name":"5FU","otherNames":["5-fluorouracil","Tolak","Fluoroplex","Efudex","Carac","Adrucil"]},{"type":"RADIATION","name":"Stereotactic Body Radiotherapy (SBRT)","otherNames":[]}],"arms":[{"label":"Modified FOLFIRINOX","type":"ACTIVE_COMPARATOR"},{"label":"Modified FOLFIRINOX plus Stereotactic Body Radiotherapy","type":"EXPERIMENTAL"}],"summary":"The goal of this study is to determine the safety and efficacy of a chemotherapy regimen known as Modified FOLFIRINOX (mFFX) alone or with the addition of Stereotactic Body Radiotherapy (SBRT). We hope to learn if this new treatment combination helps to control the disease and improve survival for patients with locally advanced pancreatic cancer.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"38 months","effectByArm":[{"arm":"Modified FOLFIRINOX","deltaMin":6.5,"sd":6.6},{"arm":"Modified FOLFIRINOX Plus Stereotactic Body Radiotherapy","deltaMin":8.4,"sd":9.5}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":10},"locations":{"siteCount":9,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":12},"commonTop":["Fatigue","Anemia","Platelet count decreased","Nausea","Pain, abdominal"]}}